A FIH Trial of the STREAMLINE™ SURGICAL SYSTEM
- Conditions
- Intraocular PressureOpen Angle Glaucoma
- Registration Number
- NCT04700189
- Lead Sponsor
- New World Medical, Inc.
- Brief Summary
The purpose of this study is to evaluate the safety and Intraocular pressure lowering effectiveness of the Streamline™ Surgical System.
- Detailed Description
This is a prospective, nonrandomized, open-label study evaluating the safety and IOP-lowering effectiveness of CPI Visco-Surgical System (STREAMLINE™ SURGICAL SYSTEM) in patients with open-angle glaucoma undergoing cataract surgery.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 42
Subjects must meet all the following criteria in order to be eligible for participation in this study:
- Subjects qualifying for cataract surgery
- Subjects with diagnosis of open-angle glaucoma in at least one eye with unmedicated IOP of 21-36 mmHg.
-
Subjects are ineligible for participation in this study if s/he meets any of the following criteria:
- Patients who could not be washed-out of IOP-lowering medications. .
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Proportion of unmedicated eyes with intraocular pressure (IOP) reduction of ≥20% From Baseline at Month 12 Descriptive
- Secondary Outcome Measures
Name Time Method Changes from baseline in number of IOP lowering medications From Baseline at Month 12 Exploratory analysis
Changes from baseline in intraocular pressure (IOP) From Baseline at Month 12 Exploratory analysis
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Dr. Gabriel S. Lazcano Gomez
🇲🇽Puerto Mexico, Mexico
Dr. Gabriel S. Lazcano Gomez🇲🇽Puerto Mexico, Mexico